NCT07486817
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07486817
Title Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA | ESP | DEU | AUS


No variant requirements are available.